Genomic Vision

AmCare Genomics said that it has a large network that would enable it to raise awareness about Genomic Vision's test for facioscapulohumeral muscular dystrophy. 

The growth was driven in part by a strong increase in revenues for the company's life sciences research products.

APG Bio will distribute the products and services to life science researchers in China, Hong Kong, and Macau.

The company attributed the decline to lower revenues from its collaboration with Quest Diagnostics.

Product sales rose nearly 23 percent during the year, but this was offset by a 34 percent dip in revenue from an R&D collaboration with Quest Diagnostics.

The French molecular diagnostics company said almost 95 percent of its revenue during the quarter came from its R&D collaboration with Quest Diagnostics.

The company and the hospital will conduct a clinical study into the detection and prevention of the disease.

Under the arrangement, the partners will use Genomic Vision's molecular combing technology to identify genetic variations underlying different diseases.

A 56 percent increase in revenues from the French molecular diagnostic firm's collaboration with Quest Diagnostics drove up overall revenue growth. 

The firm said the drop in revenues was due to a lack of milestone payments from Quest Diagnostics, which accounted for half of all revenues in the prior-year period.

Pages

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.